Page 7 - Maintenance Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Multiple Myeloma Induction Challenges and Future Options

Experts discuss challenges in induction regimens for transplant ineligible myeloma patients, and evolving approaches, quad regimens, dynamic frailty, and upcoming trials shaping future treatment options.

Frontline insightsMultiple myeloma treatmentMyeloma induction challengesMultiple myelomaMyeloma treatmentNewly diagnosed patientsMrd negative remissionTherapeutic goalsToxicity managementIndividualized approachQuadruplet therapyFrailty assessmentsClinical trialsTreatment regimensMyeloma inductionTransplant ineligible

Highlights from ASH 2023 in Transplant-Eligible NDMM

Experts in multiple myeloma discuss highlights from the ASH 2023 meeting around transplant-eligible NDMM with particular focus on the PERSEUS and GRIFFIN trials and the clinical implications of the results of these studies.

Multiple myelomaNewly diagnosed multiple myelomaMm treatmentTransplant eligibleGriffin trialPerseus trialMaintenance therapyMash 2023

U S FDA Approves Takeda s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

U S FDA Approves Takeda s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesGiles platfordVan doornDemyelinating polyneuropathyElisa butlerEuropean unionEuropean medicines agencyCommittee for medicinal products human useDrug administrationEuropean commissionTakeda pharmaceutical company limitedExchange commissionEuropean union summary of product characteristicsFoundation internationalProduct serviceMaintenance therapy

Continuity of Care During Maintenance Therapy

A discussion about how ensuring continuity of care for patients with AML on maintenance therapy with a focus on how the care team can coordinate to ensure best outcomes.

Optimizing outcomesLong term managementPatients withCare during maintenanceAcute myeloid leukemiaAml treatmentAcute myeloid leukemia treatmentMaintenance therapyMaintenance treatmentContinuity of careTreatment of patients with amlTreating amlTreating acute myeloid leukemia

Maintenance Therapy for Patients With AML

A review of recent data regarding maintenance therapy for patients with AML who achieve first remission, including updates from the 2023 ASH Annual meeting.

Optimizing outcomesLong term managementPatients withAcute myeloid leukemiaAml treatmentAcute myeloid leukemia treatmentMaintenance therapyMaintenance therapy optionsTreatment decisionsAml treatment landscapeAcute myeloid leukemia treatment landscape